Saturday, June 29, 2013

Sheraton Philadelphia Society Hill
One Dock Street (2nd and Walnut Streets)
Philadelphia, PA 19106

  • 7:30 am – 8:00 am
  • Registration and Breakfast
  • 8:00 am – 4:20 pm
  • CME/CE-Certified Activity
  • Pre-registration is recommended but not required.
    Seating to be based on arrival order; early arrival is recommended

Program Overview

Major depressive disorder (MDD), a common psychiatric illness, affects nearly 21 million Americans in any given year, accounting for nearly 10% of all primary care office visits. The consequences of MDD may be severe, encompassing potentially debilitating impairments to the patient’s physical and psychological health, quality of life, as well as social, occupational, and educational functioning. The ultimate therapeutic goal for patients with MDD is durable remission, both in terms of symptom control and functional ability. Sustained remission in patients with MDD is often underachieved. The MDD Summit will prepare psychiatrists, nurses and other health care professionals with practice tools and evidence-based therapeutic strategies that will allow them to reach this goal, balancing optimal efficacy with safety and tolerability of the current pharmacological and non-pharmacological modalities of treatment.

In 2010, UMDNJ-CCOE was re-accredited by the Accreditation Council for Continuing Medical Education (ACCME)
and received Accreditation with Commendation status, the highest rating achievable by a provider of CME.